Woode G N, Zheng S L, Rosen B I, Knight N, Gourley N E, Ramig R F
J Clin Microbiol. 1987 Jun;25(6):1052-8. doi: 10.1128/jcm.25.6.1052-1058.1987.
In a previous study, different U.S. isolates of bovine rotavirus were studied for their serotypes and cross-protective properties (G. N. Woode, N. E. Kelso, T. F. Simpson, S. K. Gaul, L. E. Evans, and L. Babiuk, J. Clin. Microbiol. 18:358-364, 1983). Three viruses belonging to two different serotype groups were used as vaccines in gnotobiotic calves, which were subsequently challenged with B641 or B223, representing the two bovine serotypes. In the present work, the experiments were repeated with more calves and the specificity of their antibody responses was measured and compared with the results of the protection studies. Protection between different serotypes occurred under both homologous and heterologous conditions but was not directly serotype dependent. B223 virus showed both homologous and heterologous protection against B223 and B641 challenge viruses. This was a one-way reaction, as B641 did not induce protection against B223. Neonatal calf diarrhea virus vaccine produced neither homologous (against B641) nor heterologous (against B223) protection. The plaque reduction neutralization titers of serum antibody and coproantibody did not predict a state of protection against the challenge virus. Calves vaccinated with neonatal calf diarrhea virus or B641 developed neutralizing antibodies to their respective heterologous challenge viruses but were not protected. After challenge, the boosted coproantibody plaque reduction neutralization response to the original vaccine virus was greater than that to the challenge virus.
在之前的一项研究中,对美国不同的牛轮状病毒分离株进行了血清型和交叉保护特性研究(G.N. 伍德、N.E. 凯尔索、T.F. 辛普森、S.K. 高尔、L.E. 埃文斯和L. 巴比尤克,《临床微生物学杂志》18:358 - 364,1983年)。属于两个不同血清型组的三种病毒被用作无菌小牛的疫苗,随后用代表两种牛血清型的B641或B223进行攻毒。在本研究中,用更多的小牛重复了实验,并测量了它们抗体反应的特异性,并与保护研究的结果进行了比较。不同血清型之间的保护在同源和异源条件下均会发生,但并非直接依赖血清型。B223病毒对B223和B641攻毒病毒均表现出同源和异源保护。这是一种单向反应,因为B641不能诱导对B223的保护。新生小牛腹泻病毒疫苗既不能产生同源(针对B641)保护也不能产生异源(针对B223)保护。血清抗体和粪便抗体的蚀斑减少中和效价不能预测对攻毒病毒的保护状态。用新生小牛腹泻病毒或B641疫苗接种的小牛产生了针对各自异源攻毒病毒的中和抗体,但未得到保护。攻毒后,对原始疫苗病毒的粪便抗体蚀斑减少中和反应增强,大于对攻毒病毒的反应。